Citadel Advisors
CELUW icon

Citadel Advisors’s Celularity Inc CELUW Stock Holding History

Citadel Advisors’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,583
Closed -$580 – 14628
2023
Q4 		$580 Sell
14,583
-5,992
-29% -$103 ﹤0.01% 13999
2023
Q3 		$313 Buy
20,575
+5,984
+41% +$206 ﹤0.01% 14089
2023
Q2 		$836 Buy
+14,591
New +$881 ﹤0.01% 14039

Other funds holding CELUW

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
WCM
Weaver Capital Management Suwanee, Georgia $461M AUM 20.77% 1-Year Est. Return

Citadel Advisors's CELUW Position: Q1 2024 in Review

Citadel Advisors sold out of Celularity Inc (CELUW) in Q1 2024, closing a stake of 14,583 shares — an estimated $580 sold.

Citadel Advisors first reported a position in CELUW in Q2 2023 and held it in 3 quarters. The position peaked at $836 in Q2 2023. 12 funds tracked by Wall St. Rank hold CELUW as of Q1 2024.

  • Citadel Advisors reported no remaining Celularity Inc position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 14,583 Celularity Inc shares in Q1 2024, an estimated $580.
  • Citadel Advisors first reported a position in Celularity Inc in Q2 2023 and held it in 3 quarters.
  • Citadel Advisors's Celularity Inc position peaked at $836 in Q2 2023.
  • 12 funds tracked by Wall St. Rank held Celularity Inc as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.